Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITDAEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Summit Therapeutics (SMMT) Shares Outstanding (2018 - 2025)

Summit Therapeutics' Shares Outstanding history spans 8 years, with the latest figure at $744.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 1.0% year-over-year to $744.4 million; the TTM value through Sep 2025 reached $744.4 million, up 1.0%, while the annual FY2024 figure was $737.6 million, 5.13% up from the prior year.
  • Shares Outstanding reached $744.4 million in Q3 2025 per SMMT's latest filing, roughly flat from $742.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $744.4 million in Q3 2025 to a low of $82.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $468.9 million, with a median of $697.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 611.04% in 2023, then grew 0.61% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $98.0 million in 2021, then soared by 115.31% to $211.1 million in 2022, then surged by 232.4% to $701.7 million in 2023, then increased by 5.13% to $737.6 million in 2024, then rose by 0.92% to $744.4 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Shares Outstanding are $744.4 million (Q3 2025), $742.8 million (Q2 2025), and $741.6 million (Q1 2025).